STAT News

STAT+: China moves to restrict foreign biotech acquisitions

China is proposing new restrictions on foreign acquisitions of critical biopharma technologies, as the country seeks to retain control over its burgeoning drug development industry.

By STAT News

1 min read
STAT+: China moves to restrict foreign biotech acquisitions
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights